Everence Capital Management’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-16,000
Closed -$240K 797
2021
Q4
$240K Buy
+16,000
New +$291K 0.02% 674
2021
Q3
Sell
-4,720
Closed -$236K 771
2021
Q2
$236K Hold
4,720
0.02% 646
2021
Q1
$217K Hold
4,720
0.02% 666
2020
Q4
$202K Buy
+4,720
New +$179K 0.02% 649
2020
Q3
Sell
-4,720
Closed -$252K 760
2020
Q2
$252K Hold
4,720
0.03% 506
2020
Q1
$247K Hold
4,720
0.03% 441
2019
Q4
$230K Hold
4,720
0.03% 570
2019
Q3
$259K Hold
4,720
0.04% 479
2019
Q2
$236K Buy
+4,720
New +$235K 0.04% 500

Other funds holding TRHC

Everence Capital Management's TRHC Position: Q1 2022 in Review

Everence Capital Management sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q1 2022, closing a stake of 16,000 shares — an estimated $240K sold.

Everence Capital Management first reported a position in TRHC in Q2 2019 and held it in 9 quarters. The position peaked at $259K in Q3 2019. 139 funds tracked by Wall St. Rank hold TRHC as of Q1 2022.

  • Everence Capital Management reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Everence Capital Management sold 16,000 Tabula Rasa HealthCare, Inc. Common Stock shares in Q1 2022, an estimated $240K.
  • Everence Capital Management first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q2 2019 and held it in 9 quarters.
  • Everence Capital Management's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $259K in Q3 2019.
  • 139 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q1 2022.

Based on Everence Capital Management's 13F filing for Q1 2022, filed 11 Apr 2022.